Zuventus Healthcare Limited, Mumbai
Harshal Amritkar is an experienced professional in supply chain management and production planning, currently serving as Assistant Manager at Zuventus Healthcare Limited in Mumbai since October 2022. Previously, Harshal held the position of Senior Executive in PPIC and Supply Chain Management at UMEDICA LABORATORIES PRIVATE LIMITED, focusing on demand and production planning for regulated and ROW markets. Prior roles include Production Planning & Inventory Control at Emcure Pharmaceuticals Ltd and Pharmaceutical Supply Chain at Parekh Integrated Service Pvt. Ltd. Harshal began the career as an MBA Summer Intern at GlaxoSmithKline Pharmaceutical Ltd, focusing on inventory management improvement. Harshal holds an MBA in Business Management and Operations from Sinhgad Institute of Management and a B.Pharm from Pune University.
Zuventus Healthcare Limited, Mumbai
The journey of Zuventus Healthcare began in 2002 when a visionary with pharmaceutical expertise instituted a pharma venture for developing therapeutic products that would improve people’s health, aid faster recovery, and empower them to lead quality lives. The mainstays of this concept were – paramount emphasis on quality, ethics, compliance to standards in operations, and making affordable medicines. A concept whose foundations were as strong as these and which was driven by an unshakeable conviction to care for life inevitably reaches its goal. From 400 employees in 2002 to 3000+ employees today, Zuventus Healthcare is the fastest growing pharma company in India with effective and robust product lines covering a range of therapeutic segments including anti-infectives, vitamins/minerals/nutrients, respiratory generics, gastrointestinal, cardiac, gynaecological, pain/analgesic, antidiabetic, cephalosporins and more available in multiple dosages forms such as tablets, capsules, injectables, and liquids. Zuventus has strong manufacturing capabilities based in Jammu, Sikkim, and Bengaluru as well as a DSIR-approved, advanced formulation R & D centre in Pune. Zuventus’s stupendous growth is evident from the fact that – the company crossed the “100-crore” mark in April 2006, the “200-crore” mark in September 2007 and were quick to achieve a turnover of 2000 crores in 20 years. Today, the company is ranked 7th in the directly covered market and overall ranked 23rd amongst the leading pharmaceutical companies in India. As we propel ahead, we will continue to push the boundaries, invest in research and technology to develop drugs and vaccines for improving patients’ wellbeing.